Cited by 115Liver Disease and TransplantationInfectious Encephalopathies and EncephalitisDrug-Induced Hepatotoxicity and Protection

Hyperammonemia in Hepatic Encephalopathy

Open access
Jayakumar, A.R., Norenberg, Michael D.·2018·Journal of Clinical and Experimental Hepatology

Abstract

The precise mechanism underlying the neurotoxicity of Hepatic Encephalopathy (HE) is remains unclear. The dominant view has been that gut-derived nitrogenous toxins are not extracted by the diseased liver and thereby enter the brain. Among the various toxins proposed, the case for ammonia is most compelling. Events that lead to increased levels of blood or brain ammonia have been shown to worsen HE, whereas reducing blood ammonia levels alleviates HE. Clinical, pathological, and biochemical changes observed in HE can be reproduced by increasing blood or brain ammonia levels in experimental animals, while exposure of cultured astrocytes to ammonium salts reproduces the morphological and biochemical findings observed in HE. However, factors other than ammonia have recently been proposed to be involved in the development of HE, including cytokines and other blood and brain immune factors. Moreover, recent studies have questioned the critical role of ammonia in the pathogenesis of HE since blood ammonia levels do not always correlate with the level/severity of encephalopathy. This review summarizes the vital role of ammonia in the pathogenesis of HE in humans, as well as in experimental models of acute and chronic liver failure. It further emphasizes recent advances in the molecular mechanisms involved in the progression of neurological complications that occur in acute and chronic liver failure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jceh.2018.06.007

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The aged liver secretes fewer neuroprotective molecules and eliminates fewer neurotoxic substances (e.g., superoxide radicals), exacerbating the accumulation of excessive oxidation products in the brain.

    “The aged liver secretes fewer neuroprotective molecules and eliminates fewer neurotoxic substances (e.g., superoxide radicals), exacerbating the accumulation of excessive oxidation products in the brain.225”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 4

  1. Nencki M, Pawlow J, Zaleski J. Ueber den ammoniakgehalt des blutes under der organe und die harnstoffbildung bei den sau- gethieren. Arch Fuer Exp Pathol Pharmakol. 1896;37:26-51.
  2. Tarantino G, Citro V, Esposito P, et al. BMC Gastroenterol. 2009;17(9):21.
  3. Jayakumar AR, Norenberg MD. Endothelial-astrocytic interac- tions in acute liver failure. Metab Brain Dis. 2013;28:183-186.
  4. Shah N, Montes de Oca M, Jover-Cobos M, et al. Role of toll-like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure. Liver Transpl. 2013;19:751-761.

Cited by

Sorted by citations

Authors
Jayakumar, A. R., & Norenberg, M. D.
Affiliations
  • Veterans Health Administration (US)
  • University of Miami (US)
Corresponding author
  • Jayakumar, A.R.
  • Norenberg, Michael D.
Venue
Journal of Clinical and Experimental Hepatology
Publisher
Elsevier BV
Published
2018-09
Volume
8
Issue
3
Pages
272-280
ISSN
0973-6883 (ISSN-L)
OpenAlex
W2808917216
Cited by
115
References
126
Citations by year
2026: 10 · 2025: 19 · 2024: 16 · 2023: 18 · 2022: 21 · 2021: 14 · 2020: 9 · 2019: 4 · 2018: 3
FWCI
1.01
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical and Experimental Hepatology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • US Department of Veterans Affairs (MDN)
  • AASLD/ALF
  • Stanley J. Glaser grant
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
hepatic encephalopathy, hyperammonemia, ammonia neurotoxicity, pathogenesis, acute liver failure, chronic liver failure, astrocytes, cytokines, neurological complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review